115 related articles for article (PubMed ID: 21723078)
1. Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal.
Chuang HY; Chang YF; Hwang JJ
Biomed Pharmacother; 2011 Jul; 65(4):286-92. PubMed ID: 21723078
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapy with fatty acid synthase inhibitors in a human prostate carcinoma LNCaP/tk-luc-bearing animal model.
Chen HW; Chang YF; Chuang HY; Tai WT; Hwang JJ
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):260-4. PubMed ID: 22565411
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibitor of fatty acid synthase suppresses growth and invasiveness of renal cancer cells.
Horiguchi A; Asano T; Asano T; Ito K; Sumitomo M; Hayakawa M
J Urol; 2008 Aug; 180(2):729-36. PubMed ID: 18555493
[TBL] [Abstract][Full Text] [Related]
5. Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: implication of reconstituted tumor microenvironment and multidrug resistance phenotype.
Kant S; Kumar A; Singh SM
Biochim Biophys Acta; 2014 Jan; 1840(1):294-302. PubMed ID: 24060750
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor.
Browne CD; Hindmarsh EJ; Smith JW
FASEB J; 2006 Oct; 20(12):2027-35. PubMed ID: 17012255
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid synthase inhibitor orlistat induces apoptosis in T cell lymphoma: role of cell survival regulatory molecules.
Kant S; Kumar A; Singh SM
Biochim Biophys Acta; 2012 Nov; 1820(11):1764-73. PubMed ID: 22877747
[TBL] [Abstract][Full Text] [Related]
8. Anticancer activities of sesquiterpene lactones from Cyathocline purpurea in vitro.
Ma G; Chong L; Li Z; Cheung AH; Tattersall MH
Cancer Chemother Pharmacol; 2009 Jun; 64(1):143-52. PubMed ID: 18998133
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
Pourgholami MH; Akhter J; Wang L; Lu Y; Morris DL
Cancer Chemother Pharmacol; 2005 May; 55(5):425-32. PubMed ID: 15565325
[TBL] [Abstract][Full Text] [Related]
10. Darbufelone, a novel anti-inflammatory drug, induces growth inhibition of lung cancer cells both in vitro and in vivo.
Ye X; Zhou W; Li Y; Sun Y; Zhang Y; Ji H; Lai Y
Cancer Chemother Pharmacol; 2010 Jul; 66(2):277-85. PubMed ID: 20352217
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic effect of flavopiridol, a small molecular cyclin-dependent kinase inhibitor, in human ovarian carcinoma].
Song Y; Shen K; Tang PP
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):761-4. PubMed ID: 18307904
[TBL] [Abstract][Full Text] [Related]
12. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
13. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
Ji YB; Zhou JH; Zuo MX; You QD
Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
[TBL] [Abstract][Full Text] [Related]
14. Application of bioluminescence imaging to therapeutic intervention of herpes simplex virus type I - Thymidine kinase/ganciclovir in glioma.
Jang SJ; Kang JH; Kim KI; Lee TS; Lee YJ; Lee KC; Woo KS; Chung WS; Kwon HC; Ryu CJ; Choi TH; Choi CW; Lim SM; Cheon GJ
Cancer Lett; 2010 Nov; 297(1):84-90. PubMed ID: 20819721
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of fatty acid synthase in human gliomas correlates with the WHO tumor grade and inhibition with Orlistat reduces cell viability and triggers apoptosis.
Grube S; Dünisch P; Freitag D; Klausnitzer M; Sakr Y; Walter J; Kalff R; Ewald C
J Neurooncol; 2014 Jun; 118(2):277-287. PubMed ID: 24789255
[TBL] [Abstract][Full Text] [Related]
16. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride.
Schmidt LJ; Ballman KV; Tindall DJ
Prostate; 2007 Jul; 67(10):1111-20. PubMed ID: 17477363
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic and toxicologic evaluation of anti-lipogenic agents in cancer cells compared with non-neoplastic cells.
Deepa PR; Vandhana S; Jayanthi U; Krishnakumar S
Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):494-503. PubMed ID: 22151915
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells.
Ahn MY; Lee J; Na YJ; Choi WS; Lee BM; Kang KW; Kim HS
Chem Biol Interact; 2009 May; 179(2-3):169-77. PubMed ID: 19070610
[TBL] [Abstract][Full Text] [Related]
20. Visualizing inhibition of fatty acid synthase through mass spectrometric analysis of mitochondria from melanoma cells.
Zecchin KG; Alberici LC; Riccio MF; Eberlin MN; Vercesi AE; Graner E; Catharino RR
Rapid Commun Mass Spectrom; 2011 Feb; 25(3):449-52. PubMed ID: 21213365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]